Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Stratum Nutrition Begins Clinical Trial for Artinia - Nutraceuticals World
Research

Stratum Nutrition Begins Clinical Trial for Artinia

Stratum Nutrition, in collaboration with its commercialization partner, KitoZyme, has received regulatory (Institutional Review Board) approval for clinical protocol and initiated recruitment and randomization for an additional clinical study on the company’s branded chitin-glucan ingredient Artinia.

To build on existing clinical evidence for this novel, vegetarian fiber, Stratum has designed a randomized, double-blind, placebo-controlled, multi-centered clinical study to evaluate the effects of Artinia on the oxidation of LDL (low-density lipoprotein). In addition, this study will assess the effects of Artinia on other established biomarkers of glycemic control, inflammation and human safety.

Artinia is a natural chitin-glucan fiber derived from the mycelium of non-genetically-modified strain of Aspergillus niger, and features the benefits of both soluble and insoluble fibers. A 12-week animal and 30-day human pilot study have been completed, and each study demonstrated that Artinia provided substantial benefits for arterial and overall heart health. For further information: www.stratumnutrition.com; www.kitozyme.com

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters